Loading...
XSTO
NNH
Market cap14mUSD
May 22, Last price  
23.30SEK
1D
2.64%
1Q
50.32%
Jan 2017
-15.27%
IPO
-53.86%
Name

New Nordic Healthbrands AB

Chart & Performance

D1W1MN
P/E
—
P/S
0.26
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
3.99%
Revenues
550m
+3.08%
201,200,000225,594,000195,302,000199,479,000203,787,000227,983,000271,949,000298,485,000305,842,000344,739,000393,708,000452,613,000450,064,000514,845,000487,501,000533,849,000550,307,000
Net income
-8m
L+24.30%
-14,391,000934,000-5,729,000311,000-4,086,0005,781,00012,375,00011,330,0009,574,00020,297,00026,523,00028,074,00017,765,00021,303,000-2,823,000-6,194,000-7,699,000
CFO
-5m
L
4,859,00010,374,0002,024,000875,0004,167,000483,0003,204,000-2,560,0001,624,00026,420,00017,852,000-667,00019,680,000-7,870,000-15,451,00028,027,000-5,400,000
Dividend
Apr 29, 20221.25 SEK/sh

Profile

New Nordic Healthbrands AB (publ) develops and markets dietary supplements, natural medicines, and cosmetic products in Sweden. The company provides vitality products for immune system. The company provides balm, repair mask, shampoo, shine serum, chewing gum, face and eye cream, and dietary supplements. It offers its products under Hair Volume, Skin Care, Beauty In & Out, and New Nordic brand names. The company sells its products through pharmacies, department stores, health stores, travel retailers, and beauty shops, as well as through online stores in 41 countries in North America, Canada, Europe, the United States, and internationally. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.
URL
https://newnordic.se/
IPO date
Jan 23, 2007
Employees
74
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
550,307
3.08%
533,849
9.51%
487,501
-5.31%
Cost of revenue
195,614
186,292
169,576
Unusual Expense (Income)
NOPBT
354,693
347,557
317,925
NOPBT Margin
64.45%
65.10%
65.22%
Operating Taxes
936
280
(2,343)
Tax Rate
0.26%
0.08%
NOPAT
353,757
347,277
320,268
Net income
(7,699)
24.30%
(6,194)
119.41%
(2,823)
-113.25%
Dividends
(7,744)
Dividend yield
4.31%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
37,065
30,692
48,347
Long-term debt
2,154
1,649
Deferred revenue
Other long-term liabilities
2,183
Net debt
23,972
16,879
31,746
Cash flow
Cash from operating activities
(5,400)
28,027
(15,451)
CAPEX
(1,219)
(2,144)
(2,954)
Cash from investing activities
(3,712)
(3,396)
(2,619)
Cash from financing activities
10,395
(21,171)
16,589
FCF
354,119
378,964
307,917
Balance
Cash
15,247
13,813
10,703
Long term investments
7,547
Excess cash
Stockholders' equity
6,195
106,030
218,949
Invested Capital
140,134
134,854
160,912
ROIC
257.29%
234.83%
211.17%
ROCE
253.10%
256.46%
197.58%
EV
Common stock shares outstanding
6,195
6,195
6,195
Price
15.00
-9.91%
16.65
-42.59%
29.00
-67.19%
Market cap
92,928
-9.91%
103,147
-42.59%
179,655
-67.20%
EV
116,900
120,026
211,401
EBITDA
354,693
349,451
319,569
EV/EBITDA
0.33
0.34
0.66
Interest
2,766
2,826
1,525
Interest/NOPBT
0.78%
0.81%
0.48%